Similar articles

• Cardiac risk assessment by gated single-photon emission computed tomography in asymptomatic end-stage renal disease patients at the start of dialysis.

  Kim JK, Kim SG, Kim HJ, Song YR. Kim JK, et al. J Nucl Cardiol. 2012 Jun;19(3):438-47. doi: 10.1007/s12350-011-9497-2. Epub 2011 Dec 28. J Nucl Cardiol. 2012. PMID: 22203446 Free PMC article. Clinical Trial.
• Myocardial perfusion SPECT "screening" at the start of dialysis.

  Bhatti S, Hakeem A. Bhatti S, et al. J Nucl Cardiol. 2012 Jun;19(3):410-1. doi: 10.1007/s12350-012-9524-y. J Nucl Cardiol. 2012. PMID: 22351493 No abstract available.
• The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease.

  Doukky R, Fughhi I, Campagnoli T, Wassouf M, Ali A. Doukky R, et al. J Nucl Cardiol. 2017 Feb;24(1):112-118. doi: 10.1007/s12350-015-0303-4. Epub 2015 Nov 18. J Nucl Cardiol. 2017. PMID: 26582040
• Cardiovascular events in Japan. Lessons from the J-ACCESS multicenter prognostic study using myocardial perfusion imaging.

  Nakajima K, Nishimura T. Nakajima K, et al. Circ J. 2012;76(6):1313-21. doi: 10.1253/circj.cj-12-0260. Epub 2012 Apr 26. Circ J. 2012. PMID: 22572460 Review.
• Aortic pulse wave velocity: an independent marker of cardiovascular risk.

  Safar ME, Henry O, Meaume S. Safar ME, et al. Am J Geriatr Cardiol. 2002 Sep-Oct;11(5):295-8. doi: 10.1111/j.1076-7460.2002.00695.x. Am J Geriatr Cardiol. 2002. PMID: 12214167 Review.